Most questions about GLP-1 peptides trace back to one ambiguity. The phrase describes a chemical shape, and it is also used as marketing language by sellers of unapproved material. Semaglutide, tirzepatide, and liraglutide are peptides and are approved prescription drugs. A vial advertised the same way may be neither reviewed nor identified.
What does GLP-1 refer to before it refers to a drug
Glucagon-like peptide-1 is a hormone released by cells lining the gut after eating. It prompts insulin secretion when glucose is high, restrains glucagon, slows how quickly the stomach empties, and reaches appetite circuits in the brain. Circulating levels fall within a couple of minutes because an enzyme clears the hormone almost immediately, which is precisely why the natural molecule was never usable as a medicine.
Every approved drug in the class solves that clearance problem in its own way. Reviews of incretin pharmacology describe the modifications, including fatty acid chains that let a molecule bind albumin and circulate for days instead of minutes. The receptor being switched on is the same one the body’s own hormone uses.
Is every drug in this class a peptide
No, and this is where the shorthand breaks. Semaglutide, tirzepatide, liraglutide, dulaglutide, and exenatide are all peptides, meaning chains of amino acids. Orforglipron is not. Sold as Foundayo and approved for reducing excess body weight and maintaining that reduction in adults with obesity or overweight with a weight-related condition, it is an oral small-molecule GLP-1 receptor agonist described as such in the New England Journal of Medicine report of its obesity program.
That distinction has a practical consequence people notice at the pharmacy counter. Small molecules survive digestion far better than peptides do, which is why orforglipron is taken as a daily tablet with or without food, while peptide products in the class either need injection or need absorption enhancers to work orally at all.
The short answers to the questions that come up most
| Question | Short answer | Where it is documented |
|---|---|---|
| Are Ozempic and Wegovy the same drug? | Same molecule, semaglutide, under separate approvals with different labeled uses and dosing ranges | DailyMed labels for each brand |
| Is there an oral semaglutide? | Yes. Tablets are co-labeled as Ozempic tablets and Rybelsus for type 2 diabetes, and the Wegovy label now covers both an injection and a tablet | DailyMed labels, revised 2026 |
| Is compounded semaglutide FDA-approved? | No. Compounded drugs are not reviewed for safety, effectiveness, or quality before marketing | FDA compounding questions and answers |
| Is a salt form the same active ingredient? | No. FDA names semaglutide sodium and semaglutide acetate as different active ingredients from the approved one | FDA statement on unapproved GLP-1 drugs |
| Does tirzepatide act on one receptor? | Two. It engages the GIP receptor alongside the GLP-1 receptor, which was a deliberate design goal from its earliest development work | Peer-reviewed pharmacology on the molecule |
Why the same molecule carries several names
Brand names are not synonyms for molecules. Each brand is a separate application, reviewed for a specific purpose, with its own trial package and its own dose range. Semaglutide holds Ozempic, Rybelsus, and Wegovy. Tirzepatide holds Mounjaro and Zepbound. Liraglutide holds Victoza and Saxenda. A list of eight brand names is a list of four molecules, and reading the molecule column first removes most of the apparent contradiction between one source and another.
Labels also move. The Zepbound label now carries an indication for moderate to severe obstructive sleep apnea in adults with obesity alongside its weight indication, and the Mounjaro label covers pediatric patients aged 10 and older for type 2 diabetes. Anything written about this class more than a year ago should be checked against the current label rather than trusted.
What people ask about cost
Price questions dominate, and the honest answer is that the number depends less on the molecule than on the pathway. A brand product filled under a pharmacy benefit costs a copay. The same product without coverage runs into four figures a month at list. Cash telehealth programs sit between those poles. Ro, Hims and Hers, LifeMD, and formblends.com each publish a flat monthly figure for physician-supervised compounded semaglutide or tirzepatide, which is a different product category from the brand and should not be read as a discount on it.
Medicare Part D has historically excluded drugs used for weight loss from required coverage, and commercial plans set their own exclusions and step requirements. That coverage gap, rather than any clinical argument, is what built the cash market in the first place.
When someone lines these programs up, the sharper question is not which is cheapest but which is clearest about the medicine. Henry Meds, Ro, and HealthRX each state that a licensed clinician reviews an intake before any compounded product ships, and services in that group tend to describe their peptide therapy options rather than list a bare number. LillyDirect takes a different route by connecting patients directly to an approved brand product. None of that closes the regulatory gap between a compounded preparation and an approved drug, but it is the layer a person can actually inspect before deciding.
Questions about vials bought online
The recurring question is whether a cheaper vial from a website contains the same substance. Nobody can answer that from the outside, and FDA has documented specific failures that make the question urgent rather than academic. Fraudulent compounded semaglutide and tirzepatide have circulated with false label information, in some cases naming compounding pharmacies that do not exist. Injectable product has arrived warm or with inadequate ice packs. An import alert was established to keep GLP-1 active pharmaceutical ingredients with potential quality concerns out of the domestic supply chain.
Reports of harm have followed. A published case series of calls to a poison control center described administration errors involving compounded semaglutide, and FDA has received adverse event reports, some involving hospitalization, connected to people measuring and self-administering incorrect amounts.
Frequently asked questions
Why can most peptide drugs not simply be taken as a pill?
Digestive enzymes break peptides apart and the gut wall absorbs large molecules poorly. Injection bypasses both problems. Oral semaglutide products get around it with an absorption enhancer and strict timing conditions, which is a different engineering answer from the one a small molecule needs.
Does compounded semaglutide come from the same manufacturer as the brand?
No. Brand products come from the approval holder’s own manufacturing. A compounded preparation is made by a compounding pharmacy or outsourcing facility from bulk active ingredient sourced separately. FDA has warned active pharmaceutical ingredient distributors selling GLP-1 material to compounders, which indicates how far apart the two supply chains are.
How can someone check whether an online pharmacy is legitimate?
FDA runs a consumer resource called BeSafeRx covering state licensure checks and the signs of an illegitimate seller. The clearest single test is whether a prescription from a licensed clinician is required before anything ships. Sites that skip that step are not pharmacies in any regulated sense.
Does this class of drug work by speeding up metabolism?
That is not the described mechanism. Published pharmacology attributes the effect to reduced appetite and food intake through receptors in the brain and gut, along with slower gastric emptying and glucose-dependent insulin release. Energy expenditure is not the lever these molecules pull.
Do the older drugs in the class still have a role?
Yes. Liraglutide products remain approved and labeled, including a weight indication covering eligible adolescents. Newer molecules produced larger average reductions in their own trials, but an older agent with a longer post-marketing record and a different dosing pattern still fits some situations better.
